[Hepatocellular carcinoma: occurrence, risk factors, biomarkers].
Fehér, János
[Hepatocellular carcinoma: occurrence, risk factors, biomarkers]. [electronic resource] - Orvosi hetilap Jun 2010 - 933-40 p. digital
Publication Type: Journal Article; Review
0030-6002
10.1556/OH.2010.28900 doi
Antineoplastic Agents--therapeutic use
Benzenesulfonates--therapeutic use
Biomarkers, Tumor--blood
Carcinoma, Hepatocellular--blood
Copper--metabolism
Developed Countries--statistics & numerical data
Developing Countries--statistics & numerical data
Hepatitis B, Chronic--complications
Hepatitis C, Chronic--complications
Humans
Incidence
Iron--metabolism
Liver Cirrhosis, Alcoholic--complications
Liver Cirrhosis, Biliary--complications
Liver Neoplasms--blood
Metabolic Diseases--complications
Niacinamide--analogs & derivatives
Phenylurea Compounds
Pyridines--therapeutic use
Risk Factors
Smoking--adverse effects
Sorafenib
[Hepatocellular carcinoma: occurrence, risk factors, biomarkers]. [electronic resource] - Orvosi hetilap Jun 2010 - 933-40 p. digital
Publication Type: Journal Article; Review
0030-6002
10.1556/OH.2010.28900 doi
Antineoplastic Agents--therapeutic use
Benzenesulfonates--therapeutic use
Biomarkers, Tumor--blood
Carcinoma, Hepatocellular--blood
Copper--metabolism
Developed Countries--statistics & numerical data
Developing Countries--statistics & numerical data
Hepatitis B, Chronic--complications
Hepatitis C, Chronic--complications
Humans
Incidence
Iron--metabolism
Liver Cirrhosis, Alcoholic--complications
Liver Cirrhosis, Biliary--complications
Liver Neoplasms--blood
Metabolic Diseases--complications
Niacinamide--analogs & derivatives
Phenylurea Compounds
Pyridines--therapeutic use
Risk Factors
Smoking--adverse effects
Sorafenib